Haematologica (Jan 2020)

High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)

  • Francesca R. Mauro,
  • Stefano Molica,
  • Stefano Soddu,
  • Fiorella Ilariucci,
  • Marta Coscia,
  • Francesco Zaja,
  • Emanuele Angelucci,
  • Francesca Re,
  • Anna Marina Liberati,
  • Alessandra Tedeschi,
  • Gianluigi Reda,
  • Daniela Pietrasanta,
  • Alessandro Gozzetti,
  • Roberta Battistini,
  • Giovanni Del Poeta,
  • Caterina Musolino,
  • Mauro Nanni,
  • Alfonso Piciocchi,
  • Marco Vignetti,
  • Antonino Neri,
  • Francesco Albano,
  • Antonio Cuneo,
  • Ilaria Del Giudice,
  • Irene Della Starza,
  • Maria Stefania De Propris,
  • Sara Raponi,
  • Anna R. Guarini,
  • Robin Foà

DOI
https://doi.org/10.3324/haematol.2019.235705
Journal volume & issue
Vol. 105, no. 11

Abstract

Read online

No abstracts available.